Chart Rhythms

Follow the rhythm behind every market move.

News Center

Source articles powering Chart Rhythms.

Browse cached source articles used by the rhythm engine. Filter by ticker, sentiment, or keyword, then open the stock rhythm page for deeper daily, swing, and long-term analysis.

Cached Articles

7738

Tickers With News

507

Showing Now

Top Ticker

Active filters:

Ticker: ABBVSentiment: BULLISHClear filters

Featured Tickers

Quick rhythm news shortcuts.

Jump straight into the most important tickers for testing and market coverage.

Search all stocks

JPM MA VEEV FICO NVDA AAPL MSFT TSLA

Ticker Filters

Browse by cached coverage.

These are the tickers with the most cached source articles right now.

Search all stocks

All C: 163 TSLA: 159 NVDA: 148 AAPL: 139 F: 138 MSFT: 116 MA: 104 A: 98 JPM: 97

4 source articles found.

Open Markets

ABBVBullishYahoo Finance • 2026-05-23Cached source

AbbVie (ABBV): 10 Best Low Risk Stocks to Buy in 2026

AbbVie Inc. (NYSE:ABBV) is highlighted as one of the best low-risk stocks for 2026, primarily due to recent clinical trial data for its IBD therapies, Skyrizi and Rinvoq. The company presented 18 abstracts showcasing the long-term efficacy, safety, and durability of these treatments for Crohn’s disease and ulcerative colitis. Despite AbbVie's potential, the article suggests that certain AI stocks might offer greater upside potential with less downside risk.

Open Source Open Stock Rhythm

ABBVBullishSeeking Alpha • 2026-05-22Cached source

AbbVie, Merck, Astra among winners of EU drug recommendations this week

The EU drug regulator's expert panel has recommended eight new medicines for approval this week, benefiting companies like Merck, AstraZeneca, and AbbVie. Merck's Keytruda, AstraZeneca's Enhertu, and AbbVie's Maviret received positive opinions for new indications, suggesting expanded market access and potential revenue growth. Pending final decisions from the European Commission could significantly impact the future revenue streams for these drugmakers by unlocking new sales volumes for larger or new patient groups.

Loading Chart Rhythms